Pfizer CEO Voices Concerns Over US Investment Due to Trump's Proposed Pharmaceutical Tariffs Uncertainty
Pfizer CEO Albert Bourla highlights how uncertainty over proposed pharmaceutical tariffs by President Trump is limiting the company's investment in the US, despite reporting an 8% ...